IBDEI0FK ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7492,0)
 ;;=871.4^^49^558^54
 ;;^UTILITY(U,$J,358.3,7492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7492,1,3,0)
 ;;=3^Laceration of Eyeball
 ;;^UTILITY(U,$J,358.3,7492,1,4,0)
 ;;=4^871.4
 ;;^UTILITY(U,$J,358.3,7492,2)
 ;;=Laceration of Eyeball^274889
 ;;^UTILITY(U,$J,358.3,7493,0)
 ;;=242.90^^49^558^108
 ;;^UTILITY(U,$J,358.3,7493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7493,1,3,0)
 ;;=3^Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,7493,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,7493,2)
 ;;=Thyroid Eye Dis^267811^376.21
 ;;^UTILITY(U,$J,358.3,7494,0)
 ;;=135.^^49^558^101
 ;;^UTILITY(U,$J,358.3,7494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7494,1,3,0)
 ;;=3^Sarcoidosis
 ;;^UTILITY(U,$J,358.3,7494,1,4,0)
 ;;=4^135.
 ;;^UTILITY(U,$J,358.3,7494,2)
 ;;=Sarcoidosis^107916
 ;;^UTILITY(U,$J,358.3,7495,0)
 ;;=446.5^^49^558^107
 ;;^UTILITY(U,$J,358.3,7495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7495,1,3,0)
 ;;=3^Temporal Arteritis
 ;;^UTILITY(U,$J,358.3,7495,1,4,0)
 ;;=4^446.5
 ;;^UTILITY(U,$J,358.3,7495,2)
 ;;=Temporal Arteritis^117658
 ;;^UTILITY(U,$J,358.3,7496,0)
 ;;=401.9^^49^558^49
 ;;^UTILITY(U,$J,358.3,7496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7496,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,7496,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,7496,2)
 ;;=Hypertension^186630
 ;;^UTILITY(U,$J,358.3,7497,0)
 ;;=V72.0^^49^558^32
 ;;^UTILITY(U,$J,358.3,7497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7497,1,3,0)
 ;;=3^Eye Exam
 ;;^UTILITY(U,$J,358.3,7497,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,7497,2)
 ;;=Eye Exam^43432
 ;;^UTILITY(U,$J,358.3,7498,0)
 ;;=V41.0^^49^558^91
 ;;^UTILITY(U,$J,358.3,7498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7498,1,3,0)
 ;;=3^Problems with Sight
 ;;^UTILITY(U,$J,358.3,7498,1,4,0)
 ;;=4^V41.0
 ;;^UTILITY(U,$J,358.3,7498,2)
 ;;=^295427
 ;;^UTILITY(U,$J,358.3,7499,0)
 ;;=998.59^^49^558^89
 ;;^UTILITY(U,$J,358.3,7499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7499,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,7499,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,7499,2)
 ;;=Post Op Infection^97081
 ;;^UTILITY(U,$J,358.3,7500,0)
 ;;=042.^^49^558^1
 ;;^UTILITY(U,$J,358.3,7500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7500,1,3,0)
 ;;=3^AIDS,Unspec
 ;;^UTILITY(U,$J,358.3,7500,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,7500,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,7501,0)
 ;;=053.29^^49^558^43
 ;;^UTILITY(U,$J,358.3,7501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7501,1,3,0)
 ;;=3^Herpes Zoster,Oth
 ;;^UTILITY(U,$J,358.3,7501,1,4,0)
 ;;=4^053.29
 ;;^UTILITY(U,$J,358.3,7501,2)
 ;;=^266555
 ;;^UTILITY(U,$J,358.3,7502,0)
 ;;=054.40^^49^558^42
 ;;^UTILITY(U,$J,358.3,7502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7502,1,3,0)
 ;;=3^Herpes Simplex
 ;;^UTILITY(U,$J,358.3,7502,1,4,0)
 ;;=4^054.40
 ;;^UTILITY(U,$J,358.3,7502,2)
 ;;=^266562
 ;;^UTILITY(U,$J,358.3,7503,0)
 ;;=190.1^^49^558^83
 ;;^UTILITY(U,$J,358.3,7503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7503,1,3,0)
 ;;=3^Orbit Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,7503,1,4,0)
 ;;=4^190.1
 ;;^UTILITY(U,$J,358.3,7503,2)
 ;;=^267272
 ;;^UTILITY(U,$J,358.3,7504,0)
 ;;=190.2^^49^558^50
 ;;^UTILITY(U,$J,358.3,7504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7504,1,3,0)
 ;;=3^Lac Gland Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,7504,1,4,0)
 ;;=4^190.2
 ;;^UTILITY(U,$J,358.3,7504,2)
 ;;=^267273
 ;;^UTILITY(U,$J,358.3,7505,0)
 ;;=190.7^^49^558^52
 ;;^UTILITY(U,$J,358.3,7505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7505,1,3,0)
 ;;=3^Lac Sac Nasolac Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,7505,1,4,0)
 ;;=4^190.7
